Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Prospective Open Label Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

NCT04662723 is registered in ClinicalTrials.gov with Fondazione Schena as lead sponsor.

NCT NCT04662723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Prospective Open Label Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
Lead sponsor
Fondazione Schena
Phase
Phase 4
Overall status
Recruiting
Start date
May 1, 2023
Completion date
December 31, 2028
Enrollment
878 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glomerulonephritis, immunoglobulin a nephropathy